Selective estrogen receptor modulators suppress mesangial cell collagen synthesis

被引：75

作者：

Neugarten, J ^{[1
]}

Acharya, A ^{[1
]}

Lei, J ^{[1
]}

Silbiger, S ^{[1
]}

机构：

[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Nephrol, Bronx, NY 10467 USA

来源：

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 2000年 / 279卷 / 02期

关键词：

estradiol; angiotensin II; transforming growth factor-beta(1); endothelin;

D O I：

10.1152/ajprenal.2000.279.2.F309

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Estrogen receptor modulators (SERMs) are "designer drugs" that exert estrogen-like actions in some cells but not in others. We examined the effects of the SERMs LY-117018 (an analog of raloxifene) and tamoxifen on mesangial cells synthesis of type I and type IV collagen. We found that LY-117018 and tamoxifen suppressed mesangial cell type IV collagen gene transcription and type IV collagen protein synthesis in a dose-dependent manner, with a potency identical to that of estradiol. Type I collagen synthesis was also suppressed by LY-117018 in a dose-dependent manner with a potency identical to that of estradiol but greater than that of tamoxifen. Genistein, which selectively binds to estrogen receptor-beta in nanomolar concentrations, suppressed type I and type IV collagen synthesis, suggesting that estrogen receptor-beta mediates the effects of estrogen on collagen synthesis. Because matrix accumulation is central to the development of glomerulosclerosis, second-generation SERMs may prove clinically useful in ameliorating progressive renal disease without the adverse effects of estrogen on reproductive tissues.

引用

页码：F309 / F318

页数：10

共 37 条

[31] Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1 [J].

Silbiger, S ;

Lei, J ;

Neugarten, J .

KIDNEY INTERNATIONAL, 1999, 55 (04) :1268-1276

[32] Estradiol reverses TGF-β1-stimulated type IV collagen gene transcription in murine mesangial cells [J].

Silbiger, S ;

Lei, J ;

Ziyadeh, FN ;

Neugarten, J .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (06) :F1113-F1118

[33] THE IMPACT OF GENDER ON THE PROGRESSION OF CHRONIC RENAL-DISEASE [J].

SILBIGER, SR ;

NEUGARTEN, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) :515-533

[34] Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta [J].

Tremblay, GB ;

Tremblay, A ;

Copeland, NG ;

Gilbert, DJ ;

Jenkins, NA ;

Labrie, F ;

Giguere, V .

MOLECULAR ENDOCRINOLOGY, 1997, 11 (03) :353-365

[35] TAMOXIFEN ACTIVATION OF THE ESTROGEN RECEPTOR/AP-1 PATHWAY - POTENTIAL ORIGIN FOR THE CELL-SPECIFIC ESTROGEN-LIKE EFFECTS OF ANTIESTROGENS [J].

WEBB, P ;

LOPEZ, GN ;

UHT, RM ;

KUSHNER, PJ .

MOLECULAR ENDOCRINOLOGY, 1995, 9 (04) :443-456

[36]

WOLF G, 1992, AM J PATHOL, V140, P95

[37] Identification of an estrogen response element activated by metabolites of 17 beta-estradiol and raloxifene [J].

Yang, NN ;

Venugopalan, M ;

Hardikar, S ;

Glasebrook, A .

SCIENCE, 1996, 273 (5279) :1222-1225

← 1 2 3 4 →